CG Oncology, Inc. (CGON) Total liabilities 2023–2025
CG Oncology, Inc. (CGON) total liabilities at each fiscal year-end, per SEC filings.
$39.0MFY2025 · since FY2023: $14.5M → $39.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $39.0M | +82.0% |
| FY2024 | $21.4M | +47.6% |
| FY2023 | $14.5M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More CGON financial trends
CGON RevenueCGON Net incomeCGON Net marginCGON Gross profitCGON Gross marginCGON Operating incomeCGON Operating marginCGON Operating cash flowCGON Free cash flowCGON Capital expendituresCGON Return on equityCGON Stock buybacksCGON Dividends paidCGON Total assetsCGON Shareholders’ equityCGON overview →